Cannabis Grower Aphria Rejects Green Growth’s Hostile Offer

(Bloomberg) -- Aphria Inc. has rejected a hostile takeover bid from Green Growth Brands Inc., saying it undervalues the Canadian cannabis grower.

Green Growth’s offer, made last month, represents a 23 percent discount to Aphria’s share price, based on the 20-day volume-weighted average price of Green Growth stock immediately before its bid was announced, Aphria said Wednesday in a statement. Aphria’s Canadian shares had gained more than 70 percent since Green Growth first signaled its intention to launch the offer in late December.

“Regardless of their brazen attempts to suggest otherwise, GGB is asking Aphria shareholders to accept a substantial discount on their shares,” Aphria Chairman Irwin Simon said in the statement.

He indicated that Aphria’s board would be more open to a cash bid than the all-stock offer from Green Growth.

“There’s a big difference between cash and someone else’s paper,” Simon said in an interview Wednesday on BNN Bloomberg TV.

Unsolicited Offer

Columbus, Ohio-based Green Growth formally launched the unsolicited offer in January following an attack on Aphria by short sellers. Based on Tuesday’s closing prices, the offer is worth C$2.3 billion ($1.74 billion), well below Aphria’s current market value of C$3.3 billion. The gap between Green Growth’s offer and Aphria’s current share price is the third widest of the 101 current deals tracked by Bloomberg.

Aphria shares closed down 8.9 percent in Toronto Wednesday and Green Growth dropped 6.6 percent amid a broader decline in pot stocks.

Green Growth said it believes combining its business with Aphria will benefit both groups of shareholders.

“The combined entity of Aphria and GGB would create an unparalleled North American player with both Canadian and U.S. operations,” Green Growth said in a statement late Wednesday.

Cross-Border

If the bid succeeds, it would mark the first large cross-border takeover in the cannabis industry. Canada legalized recreational pot in October, and several U.S. states allow medical or recreational use of the drug, but it remains banned at the federal level.

Under the terms of the offer, Aphria investors have until May 9 to tender their shares.

The Canadian company said a deal would “destroy value” for shareholders by reducing interest from potential strategic partners. It would result in Aphria shareholders giving Green Growth investors a 36 percent interest “in exchange for shares in a company with limited operations or other experience in the cannabis industry,” according to the statement.

It would also force the combined company to immediately delist from the Toronto Stock Exchange and the New York Stock Exchange, which don’t allow listings from cannabis companies with U.S. operations, reducing liquidity for Aphria shareholders, the company said.

Timed to ‘Exploit’

“GGB clearly timed their offer to exploit recent lows for Aphria and cannabis stocks overall, with the goal of transferring value to the insiders who control GGB at the expense of Aphria shareholders,” Simon said in the statement.

Green Growth also plans to complete a third-party equity financing of C$300 million at C$7 a share to fund the deal. Its shares closed at C$5.47 on Wednesday.

Its largest shareholder, backed by the retail fortune of Ohio’s Schottenstein family, has agreed to purchase up to C$150 million shares to backstop the financing, but Aphria said there’s no guarantee it will be able to complete it.

Scotiabank, which is acting as financial adviser to Aphria, provided a written opinion that the bid is inadequate, the company said.

(Updates with comment from Green Growth in eighth paragraph.)

To contact the reporters on this story: Eric Pfanner in London at [email protected];Kristine Owram in Toronto at [email protected]

To contact the editors responsible for this story: Eric Pfanner at [email protected], Steven Frank, Carlos Caminada

For more articles like this, please visit us at bloomberg.com

©2019 Bloomberg L.P.